Objective: To estimate the prevalence and characteristics of urinary incontinence (UI) in the noninstitutionalized elderly population of Madrid, Spain. Methods: We carried out a cross-sectional study in a representative sample of all community-dwelling people aged 65 or over. Subjects were interviewed in their homes. The question: Do you currently experience any difficulty in controlling your urine? ... In other words, does your urine escape involuntarily? was used to identify UI. Type of UI, use of absorbents and specific drugs were also assessed, as well as consultation behavior. Results: 589 persons were interviewed (response rate: 71.2%). The prevalence of UI was 15.5%. No significant difference was observed between men and women. Urge UI was the main type for men and mixed UI for women. Use of pads was referred by 20.2%. A total of 34.3% of subjects never went to the doctor for their problem (25.2% of men and 39.4% of women). Conclusion: Compared to other populations the overall prevalence of UI in Spanish elders living at home is relatively high. A very small difference by gender was found, although a lower response rate in women could in part explain this unexpected finding.

Keywords:
Urinary incontinence, Prevalence, Epidemiology, Aged
1.
Fonda D, Ouslander JG, Norton C: Continence across the continents. J Am Geriatr Soc 1994;42:109–112.
2.
Fultz NH, Herzog AR: Epidemiology of urinary symptoms in the geriatric population. Urol Clin North Am 1996;23:1–10.
3.
Barry MJ, Fowler FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett ATK: The American symptom index for benign prostatic hyperplasia. J Urol 1992;148:1549–1557.
4.
Vela Navarrete R, Martín-Moreno JM, Calahorra FJ, Damián J, Hernández Coronado A, Boyle P: Validación cultural y lingüística en castellano del Baremo Internacional de Síntomas Prostáticos. Actas Urol Esp 1994;18:841–847.
5.
Diokno AC, Brock BM, Brown MB, Herzog AR: Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol 1986;136:1022–1025.
6.
Brocklehurst JC: Urinary incontinence in the community – Analysis of a MORI poll. BMJ 1993;306:832–834.
7.
Thomas TM, Plymat KR, Blannin J, Meade TW: Prevalence of urinary incontinence. Br Med J 1980;281:1243–1245.
8.
Ju CC, Swan LK, Merriman A, Choon TE, Viegas O: Urinary incontinence among the elderly people of Singapore. Age Ageing 1991;20:262–266.
9.
Nakanishi N, Tatara K, Naramura H, Fujiwara H, Takashima Y, Fukuda H: Urinary and faecal incontinence in a community-residing older population in Japan. J Am Geriatr Soc 1997;45:215–219.
10.
Kok AL, Voorhorst FJ, Burger CW, van Houten P, Kenemans P, Janssens J: Urinary and faecal incontinence in community-residing elderly women. Age Ageing 1992;21:211–215.
11.
Milsom I, Ekelund P, Molander U, Arvidsson L, Areskoug B: The influence of age, parity, oral contraception, hysterectomy and menopause on the prevalence of urinary incontinence in women. J Urol 1993;149:1459–1462.
12.
Brown JS, Seeley DG, Fong J, Black DM, Ensrud KE, Grady D: Urinary incontinence in older women: Who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol 1996;87:715–721.
13.
Cundiff GW, Harris RL, Coates KW, Bump RC: Clinical predictors of urinary incontinence in women. Am J Obstet Gynecol 1997;177:262–266.
14.
Kelsey JL, O’Brien LA, Grisso JA, Hoffman S: Issues in carrying out epidemiologic research in the elderly. Am J Epidemiol 1989;130:857–866.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.